JavaScript is disabled in your browser. You can still read and search, but features like search previews, menus, and forms may not work until it's enabled.
Skip to content
Abstract
An abstract is not available for this content. As you have access to this content, full HTML content is provided on this page. A PDF of this content is also available in through the 'Save PDF' action button.
Create a free account to bookmark articles, vote on relevance, generate your own syntheses, and join the discussion.
Related reading
Rethinking placebo-controlled clinical trials in psychedelic therapies for psychiatric illness.
Br J Psychiatry
July 21, 2025
via PubMed
Psychedelics as Standard of Care? Many Questions Remain
Cambridge Quarterly of Healthcare Ethics
October 1, 2022
9 citations
via Semantic Scholar
The therapeutic use of psychedelic drugs: Legal, policy, and neuroscientific perspectives.
Pharmacology, biochemistry, and behavior
November 1, 2025
via PubMed
Psychedelics in Practice: Science, Safety, and the Future of Healing
PROCEEDINGS OF THE SLIIT INTERNATIONAL CONFERENCE ON ADVANCEMENTS IN SCIENCES AND HUMANITIES [SICASH]
October 10, 2025
via Semantic Scholar
Editorial: Psychedelic-assisted psychotherapies: from clinical trials to credibility
Frontiers in Neuroscience
March 23, 2026
via DOAJ
© 2026 Mindscape Collective
Support Our Mission
Choose your preferred way to support Mindscape Collective's work in advancing consciousness research.